Session # 2420T
- Hypertrophic cardiomyopathy is a genetically heterogeneous disease with reduced penetrance.
- Genetic testing is of great utility in identifying pre-symptomatic at-risk individuals.
- VUS were detected in 46% the tested individuals and the interpretation is challenging.